HGH 15 IU - Livewell Pharmaceuticals

HGH was initially sourced from deceased human donors, limiting availability and creating safety risks. The therapy was vital for treating growth hormone deficiencies in children, but the method came to an end in 1985 after links to Creutzfeldt-Jakob disease were confirmed. That same year, Genentech introduced somatrem, the first synthetic version made via recombinant DNA technology. It was soon followed by somatropin, which became the gold standard thanks to its identical structure to natural HGH and superior safety profile.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about HGH 15 IU by Livewell Pharmaceuticals, consult with your doctor or healthcare professional.